Immix Cash from 2010 to 2025

IMMX Stock  USD 1.94  0.03  1.52%   
Immix Biopharma Cash yearly trend continues to be fairly stable with very little volatility. Cash will likely drop to about 10.9 M in 2025. Cash is the total amount of money in the form of currency that Immix Biopharma has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2010-12-31
Previous Quarter
20.1 M
Current Value
10.9 M
Quarterly Volatility
7.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immix Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immix Biopharma's main balance sheet or income statement drivers, such as Tax Provision of 12.5 K, Net Interest Income of 414.7 K or Depreciation And Amortization of 6.6 K, as well as many indicators such as Dividend Yield of 0.0, Ptb Ratio of 6.91 or Book Value Per Share of 0.88. Immix financial statements analysis is a perfect complement when working with Immix Biopharma Valuation or Volatility modules.
  
Check out the analysis of Immix Biopharma Correlation against competitors.
For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.

Latest Immix Biopharma's Cash Growth Pattern

Below is the plot of the Cash of Immix Biopharma over the last few years. Cash refers to the most liquid asset of Immix Biopharma, which is listed under current asset account on Immix Biopharma balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Immix Biopharma customers. The amounts must be unrestricted with restricted cash listed in a different Immix Biopharma account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Immix Biopharma's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immix Biopharma's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Immix Cash Regression Statistics

Arithmetic Mean5,462,250
Geometric Mean1,832,947
Coefficient Of Variation137.95
Mean Deviation6,544,191
Median734,014
Standard Deviation7,535,366
Sample Variance56.8T
Range19.7M
R-Value0.76
Mean Square Error25.5T
R-Squared0.58
Significance0.0006
Slope1,207,057
Total Sum of Squares851.7T

Immix Cash History

202510.9 M
202420.1 M
202317.5 M
202213.4 M
202117.6 M
2020391.1 K

Other Fundumenentals of Immix Biopharma

Immix Biopharma Cash component correlations

About Immix Biopharma Financial Statements

Immix Biopharma investors use historical fundamental indicators, such as Immix Biopharma's Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immix Biopharma. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immix Stock Analysis

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.